| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-11 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-10 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |